Close

Soros buys Horizon Therapeutics, First Horizon, adds to Alphabet, cuts Amazon Feb 14, 2023 05:20AM
Pfizer (PFE) Completes Acquisition of Biohaven Pharmaceuticals Oct 3, 2022 01:01PM
Pfizer Completes Acquisition of Biohaven Pharmaceuticals Oct 3, 2022 01:01PM
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial Jul 6, 2022 01:00PM
Pfizer (PFE) Acquires Biohaven Pharmaceuticals (BHVN) for $148.50/sh or $11.6B in Cash May 10, 2022 06:55AM


May 10, 2022 06:45AM Pfizer to Acquire Biohaven Pharmaceuticals
Apr 27, 2022 06:45AM Pfizer (PFE) and Biohaven’s (BHVN) VYDURA Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
Apr 27, 2022 06:45AM Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
Feb 25, 2022 07:00AM Biohaven Pharma (BHVN) Pfizer (PFE) Receive Positive CHMP Opinion for Migraine Treatment
Feb 25, 2022 06:59AM Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Feb 14, 2022 07:01AM Biohaven Pharma (BHVN), Pfizer (PFE) Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Feb 14, 2022 07:00AM Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Jan 25, 2022 07:30AM Biohaven's Nurtec® ODT Extends Partnership with Rick Ware Racing for 2022 NASCAR Cup Series and NTT INDYCAR Series
Jan 5, 2022 07:04AM Biohaven Pharma (BHVN), Pfizer (PFE) Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Jan 5, 2022 07:00AM Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Nov 9, 2021 07:51AM Biohaven Pharma (BHVN) Announces Strategic Collaboration with Pfizer (PFE) for Commercialization of Rimegepant Outside the US
Nov 9, 2021 07:46AM Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Nov 2, 2021 07:30AM Nine Line Apparel and Biohaven's Nurtec ODT Set to Honor World War II Veterans Ahead of 80th Anniversary at Phoenix Raceway
Jun 23, 2021 03:00AM Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven
May 14, 2021 07:30AM Biohaven's Nurtec® ODT Signs as Primary Partner with Rick Ware Racing for 2021 NTT INDYCAR Series Program
Apr 6, 2021 07:30AM Rick Ware Racing, Biohaven's Nurtec ODT and Nine Line Apparel Honor Fallen Service Members
Jan 18, 2021 10:10AM Biohaven Signs Cody Ware as Driver for Nurtec® ODT Chevrolet for the 2021 NASCAR Cup Series Season
Jan 5, 2021 10:00AM Biohaven's Nurtec® ODT Partners with Rick Ware Racing for 24 Hours of Daytona Entry
Dec 2, 2020 10:05AM Biohaven's Nurtec™ ODT Partners with the Rick Ware Racing Team in the 2021 NASCAR Cup Series
Dec 1, 2020 03:05AM Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
Nov 16, 2020 09:00AM Value-based agreement between Prime Therapeutics and Biohaven aims to bring NURTEC™ ODT acute migraine treatment financial protection to health plans
Jul 15, 2020 07:30AM After Living with Migraine for Years, Khloé Kardashian Leads Biohaven's Take Back Today Campaign to Empower People with Migraine
Mar 13, 2020 07:30AM Biohaven Announces Patient Savings Program Where Patients Can Pay as Little as $0 for NURTEC™ ODT (rimegepant 75 mg) for the Acute Treatment of Migraine in Adults
Mar 12, 2020 04:30PM Biohaven's NURTEC™ ODT (rimegepant 75mg) is Now Available in U.S. Pharmacies for the Acute Treatment of Migraine in Adults